Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers

Mirko Manchia; Alessio Squassina; Federica Tozzi; Athos Antoniades; Bernardo Carpiniello

doi:10.2217/pgs-2022-0018

Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers

Mirko Manchia, Alessio Squassina, Federica Tozzi, Athos Antoniades, Bernardo Carpiniello

Medicine

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	277-280
Number of pages	4
Journal	Pharmacogenomics
Volume	23
Issue number	5
DOIs	https://doi.org/10.2217/pgs-2022-0018
Publication status	Published - Apr 2022

Bibliographical note

Funding Information:
This work was partly funded by Fondo Integrativo per la Ricerca 2018, granted to A Squassina, and by Fondo Integrativo per la Ricerca 2020, granted to M Manchia and B Carpiniello. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

ASJC Scopus Subject Areas

Molecular Medicine
Genetics
Pharmacology

PubMed: MeSH publication types

Editorial
Research Support, Non-U.S. Gov't

Access to Document

10.2217/pgs-2022-0018

Cite this

@article{0b2c2a802b9b45a4b7d86495aa7e20af,

title = "Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers",

author = "Mirko Manchia and Alessio Squassina and Federica Tozzi and Athos Antoniades and Bernardo Carpiniello",

note = "Funding Information: This work was partly funded by Fondo Integrativo per la Ricerca 2018, granted to A Squassina, and by Fondo Integrativo per la Ricerca 2020, granted to M Manchia and B Carpiniello. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",

year = "2022",

month = apr,

doi = "10.2217/pgs-2022-0018",

language = "English",

volume = "23",

pages = "277--280",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "5",

}

TY - JOUR

T1 - Gut microbiota and treatment-resistant schizophrenia

T2 - many questions, fewer answers

AU - Manchia, Mirko

AU - Squassina, Alessio

AU - Tozzi, Federica

AU - Antoniades, Athos

AU - Carpiniello, Bernardo

N1 - Funding Information: This work was partly funded by Fondo Integrativo per la Ricerca 2018, granted to A Squassina, and by Fondo Integrativo per la Ricerca 2020, granted to M Manchia and B Carpiniello. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85127887310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127887310&partnerID=8YFLogxK

U2 - 10.2217/pgs-2022-0018

DO - 10.2217/pgs-2022-0018

M3 - Review article

C2 - 35238627

AN - SCOPUS:85127887310

SN - 1462-2416

VL - 23

SP - 277

EP - 280

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 5

ER -

Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

Access to Document

Other files and links

Cite this